Causality Assessment
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
The structured judgment, made by the investigator and independently reviewed by the sponsor, of whether a reasonable possibility exists that an adverse event was caused by the investigational product, as opposed to the underlying disease, a concomitant medication, or chance. The outcome directly determines whether the event is an adverse reaction and whether it feeds expedited reporting.
The assessment weighs the temporal relationship between exposure and the event, response to dechallenge or rechallenge, plausible alternative explanations such as the underlying condition or other medications, and consistency with the product’s known pharmacology or prior reports.
Both the investigator’s and the sponsor’s causality judgments are documented, and they can differ; where they do, the more conservative — that is, causally related — judgment is generally the one that governs whether the case proceeds to expedited reporting.
A “related” causality assessment is precisely what converts an adverse event into an adverse reaction for regulatory reporting purposes, so the quality and consistency of this judgment has direct downstream consequences for how a signal is interpreted.
- —Considers temporal relationship, dechallenge/rechallenge response, alternative explanations, and known pharmacology of the investigational product.
- —Both investigator and sponsor assessments are documented; where they disagree, the more conservative judgment typically governs reporting.
- —A “related” causality assessment is what converts an adverse event into an adverse reaction for safety-reporting purposes.
- —Structured frameworks such as WHO-UMC causality categories are used by some organizations to standardize judgment, though no single method is universally mandated.
ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
Frequently asked questions
What is Causality Assessment?
The structured judgment, made by the investigator and independently reviewed by the sponsor, of whether a reasonable possibility exists that an adverse event was caused by the investigational product, as opposed to the underlying disease, a concomitant medication, or chance. The outcome directly determines whether the event is an adverse reaction and whether it feeds expedited reporting.
Which regulations cover Causality Assessment?
ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting